Chinese Academy of Sciences’ Investment Management unit put up a share of the proceeds for health insurance data analytics company Leyue Health’s series B round.

Taikang Life has led a series C round for the medical supplies provider that also featured 6 Dimensions Capital and Legend Capital.

Vensana has raised $225m for its first fund from LPs including university endowments and foundations as well as academic health centres.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

The multi-institution commercialisation unit has a new name to underscore its commitment to building companies on the back of its members’ research.

Sumitomo Dainippon Pharma will acquire at least 10% of Roivant in addition to its interest in five pharmaceutical subsidiaries through the deal.

Celgene-backed Repare Therapeutics secured $82.5m that will support the entry of its first cancer drug into clinical trials.

University of Pennsylvania-allied CNS disease therapy developer Passage Bio lured contributions from investors including Lilly Asia Ventures, which also featured in its $116m series A earlier this year.

MIT Media Lab spinout Ginger has raised $35m as it looks to further develop its mental and emotional health support app.

Nkarta, which is developing cell therapy treatments for cancer, has emerged from stealth with $114m in a round featuring Novo, Amgen Ventures and SR One.